Chagas Disease, A Review of the Literature
Main Article Content
Abstract
Chagas disease is a vector-borne (triatomine) infection caused by the protozoan parasite Trypanosoma cruzi. Synonyms for this disease are: American trypanosomiasis, Chagas disease and T. cruzi infection. 10, 5
The most common form of transmission of Chagas disease is through hematophagous triatomine insects (triatominae), which develop in dwellings in precarious conditions, The disease can also be transmitted by blood transfusion, organ transplantation, oral and congenital routes, and even more rarely by exceptional routes such as sexual contact and non-Triatominae vectors. American Trypanosomiasis is endemic in much of Mexico, Central and South America 1,11. it is estimated that ~6 million individuals are infected throughout Latin America, while ~300,000 are infected in the U.S.1, 10, 11,16
Chagas disease has two clearly differentiated phases. Initially, the acute phase lasts about two months after infection, they may have a skin lesion or a purplish swelling of an eyelid, they may have fever, headache, enlarged lymph nodes, pallor, muscle aches, shortness of breath, swelling, and abdominal or chest pain. During the chronic phase, the infection can cause sudden death due to cardiac arrhythmias or progressive heart failure due to destruction of the cardiac muscle and its innervations. 15
Appropriate diagnostics for acute infection, nucleic acid amplification testing (NAAT) from blood is recommended; For chronic infection, serological testing is employed. Antitrypanosomal agents, benznidazole and nifurtimox, have shown efficacy in treating T. cruzi infection, The most serious complication is chronic chagasic heart disease, since it is the main cause of death in sick patients. 16
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Ferreira-Silva, M. M., De Araújo Pereira, G., Rodrigues-Júnior, V., Meira, W. S. F., Basques, F. V., Langhi-Junior, D., Romanelli, M., Umezawa, E. S., Késper-Júnior, N., Louzada‐Neto, F., Bordin, J. O., & Moraes-Souza, H. (2021). Chagas Disease: Performance analysis of immunodiagnostic tests anti-Trypanosoma cruzi in blood donors with inconclusive screening results. Hematology, Transfusion and Cell Therapy, 43(4), 410-416. https://doi.org/10.1016/j.htct.2020.06.016
Fernández-Santos, N. A., Salazar-Schettino, P, M., Buccio-Torres, M. I., Cabrera-Bravo, M., Alba-Alvarado, C., Castillo-Saldaña. D. R, Et al. (2016). Enfermedad de Chagas en México. Revista de la Facultad de Medicina de la UNAM, 59(3), 6-16.
Kasper, D. L., Jameson, J.L., Fauci, A. S., Hauser, S. L., Longo, D. L & Loscalzo, J. (2016). Harrison Principios de Medicina Interna. New York: McGraw-Hil.
Kirchhoff, L. (2019). Trypanosoma Species (American Trypanosomiasis, Chagas' Disease): En Bennett's, J. D., Blaser, J., Dolin, R. (Eds.), Biology of Trypanosomes. Principles and Practice of Infectious Diseases. (Pp: 3481-3288). Canada: Elsevier.
Kirchhoff, L. (2021). Chagas disease: En Goldman, L., Schafer, A (Eds.), Goldman-Cecil. Tratado de Medicina Interna. (Pp: 2088-2091). España: Elsevier.
López Atuñano, et cols. (2000). Diagnosis of Chagas Disease. Revista Latinoamericana de Microbriología. Vol. 42. Pp: 121-129. http://www.medigraphic.com/pdfs/lamicro/mi-2000/mi003e.pdf
Lozano.Kasten, F., Magallón-Gastélum, E., Soto-Gutierrez, M., Kasten-Monges, M., Marie-France & B., Breniere, S. F. (2008.). Conocimiento epidemiológico y situación actual de la enfermedad de Chagas en el estado de Jalisco, México. Salud pública de méxico, 50(6), 508-515. http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342008000600012&lng=es&tlng=es.
Ministerio de Salud. Gobierno de Chile. (2011). Guía de Diagnóstico, Tratamiento y Prevención de la Enfermedad de Chagas. Santiago Chile: Ministerio de salud. https://www.ispch.cl/sites/default/files/documento/2010/04/GUIA%20CHAGAS%20publica%20febrero%202011.pdf
Norma Oficial Mexicana, Secretaría de Salud (SSA). (2010) NOM-032-SSA2-2010: Para la Vigilancia Epidemiológica, Prevención y Control de las Enfermedades Transmitidas por Vector. Ciudad de México: SSA. http://www.cenaprece.salud.gob.mx/programas/interior/vectores/descargas/pdf/nom_032_ssa2_2010_norma_petv.pdf
Pereira, M. D., Dones, W., Morillo, C. A., Encina, J. J., & Ribeiro, A. L. P. (2013). Chagas disease. Journal of the American College of Cardiology, 62(9),767-776. https://doi.org/10.1016/j.jacc.2013.05.046
Pinto-Dias J. C. (2015). Evolution of Chagas Disease Screening Programs and Control Programs. Global Heart, 10(3),193-202. https://doi.org/10.1016/j.gheart.2015.06.003
Salazar-Schettino, P. M., Bucio-Torres, M., Cabrera-Bravo, M & Ruiz-Hernandez A.L. (2011). Presentación de dos casos de enfermedad de Chagas aguda en México. Gaceta Médica de México. 147(1), 63-69. https://www.anmm.org.mx/bgmm/2011/1/P%C3%A1ginas%20de%20GMM_Vol_147_-_1_2011-63-69.pdf
Second report of the WHO Expert Committee. (2002). Control of Chagas Disease. Geneva. WHO Technical Report Series. http://apps.who.int/iris/bitstream/10665/42443/1/WHO_TRS_905.pdf
Shelly, E., Acuňa-Soto, R., Ernst, K. C., Sterling, C. R., & Brown, H. E. (2016). A critical assessment of officially reported Chagas disease surveillance data in Mexico. Public Health Reports, 131(1), 59-66. https://doi.org/10.1177/003335491613100112
The Center for Food Security & Public Health. (2017). American Trypanosomiasis. Institute for International Cooperation in Animal Biologics. 13.http://www.cfsph.iastate.edu/Factsheets/pdfs/trypanosomiasis_american.pdf
Whitman, J. D. (2023). Chagas Disease: A review and perspective on laboratory diagnostics in the United States. Clinical Microbiology Newsletter, 45(17), 141-149. https://doi.org/10.1016/j.clinmicnews.2023.09.001